Zepbound
strong$550-$1,086/mo cash price
Identical tirzepatide molecule labeled for chronic weight management. Same dosing strengths.
Preferred labeling when weight loss is the primary indication and coverage requires it.
View Zepbound on GLP1ZoomAlternatives
Mounjaro alternatives — what to ask your prescriber
A printable summary of therapeutic alternatives to Mounjaro (tirzepatide), the current FDA generic-status outlook, and the questions to bring to your prescriber visit.
These are therapeutic alternatives, NOT FDA-approved generic substitutes. Therapeutic alternatives are different medications in a similar drug class. A true generic requires FDA ANDA approval — and as of 2026, only liraglutide (Victoza / Saxenda) has an FDA-approved generic among GLP-1 medications. Only your prescriber can recommend or approve a switch.
Generic Mounjaro: not available until ~~2036-2039
Active ingredient
tirzepatide
FDA generic status
Not yet approved
Patent / NDA holder
Eli Lilly
Estimated generic year
~2036-2039
Same molecule as Zepbound. Patent stack extends past 2036 in the US.
Therapeutic alternatives, by category
Equivalence strength reflects shared mechanism of action plus the depth of head-to-head clinical evidence. Costs are US cash-price estimates and vary widely by pharmacy, insurance, and manufacturer copay programs.
Same drug class, different molecule
Ozempic
strong$935-$1,000/mo cash price
Pure GLP-1 (semaglutide). Less A1c reduction in head-to-head SURPASS-2 trial, but longer post-market safety experience.
A prescriber may step-down to semaglutide if dual agonist side-effects are intolerable.
View Ozempic on GLP1ZoomTrulicity (dulaglutide)
moderate$945-$985/mo cash price
Established once-weekly GLP-1 with REWIND CV-outcome data. Lower glycemic + weight-loss effect than tirzepatide.
Useful for patients prioritising long-term CV evidence.
View Trulicity (dulaglutide) on GLP1Zoom
FDA-approved generic liraglutide
Different drug class (non-GLP-1)
Metformin (high-dose, off-label combination)
weak$4-$25/mo cash price
First-line type 2 diabetes therapy; modest weight effect. Often used alongside a GLP-1, not as a true replacement.
Cheapest option but won't replicate tirzepatide weight-loss outcomes.
Non-pharmaceutical / lifestyle
Structured lifestyle + RD-supervised nutrition
weak$0-$250/mo cash price
No medication side-effect risk. Average weight loss with intensive lifestyle programs is 5-10% of body weight over 12 months — meaningful for some patients, well below GLP-1 efficacy for others.
Often combined with — not replacing — GLP-1 therapy; insurance may cover RD visits under obesity-care benefits.
Talk to a prescriber
Bring this summary to a visit, or connect with a telehealth GLP-1 prescriber who can review your insurance, dosing history, and tolerability before recommending any switch.
FAQ
- Is there a generic version of Mounjaro?
- No. There is no FDA-approved generic tirzepatide as of 2026. Same molecule as Zepbound. Patent stack extends past 2036 in the US.
- When will generic Mounjaro be available?
- Estimated US generic availability: ~2036-2039. This is an estimate based on USPTO Orange Book exclusivity and composition-of-matter patent expiry. Same molecule as Zepbound. Patent stack extends past 2036 in the US.
- Is compounded tirzepatide the same as a generic?
- No. Compounded products are prepared by licensed compounding pharmacies and are NOT FDA-approved as finished drugs. They have not undergone FDA bioequivalence testing and are not legally substitutable the way a true ANDA-approved generic would be.
- Can I switch from Mounjaro to one of these alternatives on my own?
- No. Switching GLP-1 medications requires a prescriber's clinical judgment about your indication, dose-titration history, side-effect tolerance, and insurance coverage. The alternatives listed here are options to DISCUSS with your prescriber — not recommendations.
Compare GLP-1 telehealth providers
SponsoredPartner offers first — we earn a commission from those — then ranked by our editorial score. Visit a partner to check current pricing and eligibility — we compare providers, we never sell medications.
Advertising disclosure: we may earn a commission if you sign up through these links, at no extra cost to you — it never affects our rankings. How we make money
- Sesame Care· from $208/moTop ratedTelehealth · online visit
- SkinnyRx· from $199/moCompounded not offered in AL, LA, MS — check before startingTelehealth · online visitCompounded · not FDA-approved
- Enhance MD· price shown after their intakeNo lab work to startRestricted in AL, AR, GA, HI, LA, MS, MO, ND, SC, TN, WV — check before startingTelehealth · online visitCompounded · not FDA-approved
- HealthRX· from $165/moLowest starting priceon the 12-month plan, $1,188 billed upfrontTelehealth · online visitCompounded · not FDA-approved